SCHEMBL4787281

SCHEMBL4787281

O=S(=O)(c1ccc(Cl)c2nonc12)N1CCc2ccc(Cl)cc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.47
LMNA P02545 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ACLY P53396 1/20 0.43
AKR1C1 Q04828 1/20 0.43
PKM P14618 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
TSHR P16473 2/20 0.41
ALOX15 P16050 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
MAPK1 P28482 1/20 0.41
NLRP3 Q96P20 1/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787836 0.95 AKR1C3 (0.47) AKR1C3LMNATDP1ALDH1A1MEN1
SCHEMBL4787833 0.81 AKR1C3 (0.40) AKR1C3LMNATDP1ALDH1A1MEN1
SCHEMBL4788142 0.79 ESR1 (0.50) AKR1C3LMNATDP1ALDH1A1MEN1
SCHEMBL4788040 0.79 SMN1; SMN2 (0.41) AKR1C3LMNATDP1ALDH1A1MEN1
SCHEMBL4786646 0.77 AKR1C3 (0.41) AKR1C3LMNAALDH1A1MEN1KMT2A
SCHEMBL5286887 0.76 POLB (0.56) LMNATDP1ALDH1A1MEN1KMT2A
SCHEMBL4787181 0.75 PKM (0.42) AKR1C3LMNAALDH1A1MEN1KMT2A
SCHEMBL6445555 0.73 HSD11B1 (0.60) AKR1C3LMNAMEN1KMT2AAKR1C1
SCHEMBL6449319 0.73 L3MBTL1 (0.64) LMNAALDH1A1MEN1KMT2APKM
SCHEMBL3153609 0.72 HTR6 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115259-A2 DERIVATIVES OF BENZOXADIAZOLE SUITABLE FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2008-09-25 WO claimed